Moreover, we showed that TRIM21 overexpression ameliorated glucose intolerance, insulin resistance, hepatic steatosis, and dyslipidemia in obese diabetic mice, whereas its knockdown promoted glucose intolerance, insulin resistance, and triglyceride accumulation. This evidence concerns the gene TRIM21 and metabolic syndrome.